|
TMS study for treatment of pain in patients with chronic pancreatitis
The Pancreas Center at Beth Israel Deaconess Medical Center is recruiting
subjects with chronic pancreatitis and pain to participate in a study of
Transcranial Magnetic Stimulation.
Many patients with chronic pancreatitis do not get relief with the current
treatments for pain. We think this may be due to increased activity in a part
of the brain that detects pain sensation from the pancreas and for which
current pain treatments do not help. Therefore, use of a treatment to affect these
activities of the brain would be a possible new approach to the relief of pain
in patients with chronic pancreatitis. This new treatment is called
Transcranial Magnetic Stimulation (TMS).
Transcranial magnetic stimulation (TMS) is a brain stimulation technique that
involves generating a brief magnetic field in a coil that is placed on your
scalp. The magnetic field passes through the skull and induces a weak
electrical current in the brain that we believe will help alleviating your pain. This
treatment is painless.
Subject selection:
You are eligible to participate in this study if:
- You are age 18 years or older
- You have daily abdominal pain for at least three months
- You DON’T have past history of seizures
- You DON’T have a vagal stimulator, deep brain stimulator or pacemeaker
- You AREN’T pregnant
- Additional inclusion and exclusion criteria will be checked by the
investigator
Procedure:
If you are eligible and willing to participate in this study, you will then receive a schedule to begin TMS. There will be 10 consecutive sessions of
Transcranial Magnetic Stimulation that will be done Monday through Friday for 2
weeks. You will be evaluated before, during and after the treatment. These
evaluations will measure your mood, anxiety, treatment response, pain and analgesic
use. There will be 20 visits to the hospital during the baseline, treatment
and follow-up period.
If you are interested in participating in this study or would like to learn
more about this study, you can contact our research coordinator - Debora
DaSilva at 617-667-5576 or ddasilva@bidmc.harvard.edu.
|